Comparison of Preoperative Frailty Assessment Tools
Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Mar 16, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 70 years and older
- • scheduled surgery
- • estimated time of surgery 120 Minutes or more
- Exclusion Criteria:
- • insufficient German language skills (for cognitive testing)
- • mental retardation
- • relevant psychiatric disorder (not allowing for cognitive testing)
Trial Officials
Dr. Cynthia Olotu, MD
Principal Investigator
University Medical Centre Hamburg
About Universitätsklinikum Hamburg Eppendorf
Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
